Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
This grant funds the development of neuromodulation and neurostimulation devices aimed at improving mental health applications.
About this program
The Neuromodulation/Neurostimulation Device Development grant supports innovative projects focused on creating devices that can enhance mental health treatment through neuromodulation techniques. This funding is intended for researchers and developers who are working on cutting-edge technologies that can provide new solutions for mental health challenges. The grant encourages the exploration of novel approaches and methodologies in the field of mental health, aiming to foster advancements that can lead to significant improvements in patient outcomes. Eligible applicants include academic institutions, research organizations, and private companies that are engaged in the development of these technologies. The grant is designed to support early-stage projects that demonstrate potential for significant impact in mental health care. Applicants are expected to outline their project goals, methodologies, and anticipated outcomes, ensuring that their proposals align with the objectives of advancing mental health treatment through innovative device development.
Eligibility
Eligible applicants include academic institutions, research organizations, and private companies focused on mental health technology development.